Nano-X Imaging Ltd. — Form 6-K Summary
Business Context and Reporting Period
Nano-X Imaging Ltd., an Israeli foreign private issuer, furnished this Form 6-K for August 2021. The filing reports that the company issued two press releases on August 10, 2021, attached as Exhibits 99.1 and 99.2.
Financial and Operating Metrics
The filing text provided does not include financial statements, revenue, profit or loss, cash flow, margins, debt, liquidity, guidance figures, or other quantitative financial metrics.
Material Changes and Announcements
The filing incorporates the two August 10, 2021 press releases by reference. The underlying press-release content is not included in the provided filing text, so the nature and materiality of the announcements cannot be determined from this excerpt.
The filing states that certain management and executive quotations in the exhibits are excluded from incorporation by reference into the company’s Form S-8 registration statement. The excluded quotations include comments by Nano-X’s chairman and chief executive officer, the co-founder and chief executive officer of Zebra Medical Vision, and the chief executive officer of USARAD.
Guidance, Risks, and Unusual Items
No specific guidance, outlook, risk factors, contingencies, or unusual financial items are disclosed in the provided text. Investors should review Exhibits 99.1 and 99.2 for the substantive announcements and related commentary.
Important Facts to Verify
- Obtain and review Exhibits 99.1 and 99.2, which contain the underlying August 10, 2021 press releases.
- Determine whether the exhibits announced business transactions, partnerships, acquisitions, regulatory developments, or operating updates.
- Verify any financial or operating metrics, forward-looking statements, and risk disclosures contained in the exhibits.
- Note that this Form 6-K itself does not provide a clear value for revenue, earnings, cash flow, debt, liquidity, or other financial measures.